Etamsylate
Etamsylate is a synthetic hemostatic agent that works by promoting platelet adhesion and restoring capillary wall resistance. It reduces bleeding time and blood loss without causing vasoconstriction or affecting the normal coagulation cascade directly.
Dosage by Body Weight
Adults typically receive 500 mg orally 3 to 4 times daily during bleeding episodes, or 250 mg to 500 mg via intravenous or intramuscular injection. Pediatric dosing is generally calculated at 10 mg to 15 mg per kg of body weight per dose, administered 3 to 4 times daily. Always consult a physician for precise instructions.
- Body Weight
- Below 5 kg
- Dose
- Not routine / 10 mg/kg
- Frequency
- Every 6 hours if prescribed
- Tracking Notes
- Strictly under specialist supervision; primarily used in clinical settings for neonatal intraventricular hemorrhage prophylaxis.
- Body Weight
- 5-7 kg
- Dose
- 50 mg to 75 mg
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Usually administered as a pediatric syrup/oral suspension.
- Body Weight
- 8-10 kg
- Dose
- 80 mg to 125 mg
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Monitor for clinical response and adjust as advised by a pediatrician.
- Body Weight
- 11-15 kg
- Dose
- 125 mg to 187 mg
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Ensure accurate measurement if using liquid formulations.
- Body Weight
- 16-20 kg
- Dose
- 160 mg to 250 mg
- Frequency
- 3 to 4 times daily
- Tracking Notes
- May use half of a standard 500 mg tablet or equivalent syrup dose.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine / 10 mg/kg | Every 6 hours if prescribed | Strictly under specialist supervision; primarily used in clinical settings for neonatal intraventricular hemorrhage prophylaxis. |
| 5-7 kg | 50 mg to 75 mg | 3 to 4 times daily | Usually administered as a pediatric syrup/oral suspension. |
| 8-10 kg | 80 mg to 125 mg | 3 to 4 times daily | Monitor for clinical response and adjust as advised by a pediatrician. |
| 11-15 kg | 125 mg to 187 mg | 3 to 4 times daily | Ensure accurate measurement if using liquid formulations. |
| 16-20 kg | 160 mg to 250 mg | 3 to 4 times daily | May use half of a standard 500 mg tablet or equivalent syrup dose. |
Formulation
Purpose
Prevention and control of hemorrhages from small blood vessels, menorrhagia (heavy menstrual bleeding), post-surgical bleeding, and neonatal intraventricular hemorrhage.
Generic Name
EtamsylateBranded Drug Names
Etamsylate is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.